Jason Carr

About the Author Jason Carr


Oppenheimer Sticks to Its Buy Rating for Sunesis Pharma (SNSS)

In a report released today, Hartaj Singh from Oppenheimer maintained a Buy rating on Sunesis Pharma (SNSS). The company’s shares closed yesterday at …

Aduro BioTech (ADRO) Receives a Buy from Oppenheimer

Oppenheimer analyst Mark Breidenbach reiterated a Buy rating on Aduro BioTech (ADRO) today. The company’s shares opened today at $3.

Oppenheimer Maintains Their Buy Rating on MEI Pharma (MEIP)

In a report released today, Leland Gershell from Oppenheimer maintained a Buy rating on MEI Pharma (MEIP). The company’s shares opened today at …

Analysts Are Bullish on These Financial Stocks: Concrete Pumping Holdings Inc (BBCP), CNO Financial (CNO)

There’s a lot to be optimistic about in the Financial sector as 3 analysts just weighed in on Concrete Pumping Holdings Inc (BBCP), …

Analysts Offer Insights on Healthcare Companies: Pieris Pharmaceuticals (PIRS) and SCYNEXIS (SCYX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Pieris Pharmaceuticals (PIRS) and SCYNEXIS …

Oppenheimer Maintains a Buy Rating on Gilead Sciences (GILD)

In a report released today, Hartaj Singh from Oppenheimer maintained a Buy rating on Gilead Sciences (GILD), with a price target of $85. …

Northland Securities Thinks PolarityTE Inc’s Stock is Going to Recover

In a report released today, Carl Byrnes from Northland Securities maintained a Buy rating on PolarityTE Inc (PTE), with a price target of …

Analysts Are Bullish on Top Consumer Goods Stocks: Telenav (TNAV), SMTC Corp (SMTX)

There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on Telenav (TNAV) and SMTC …